Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
(CAAR Delhi), the product Enviva E0 101G is a phytogenic blend designed to improve animal feed intake, gut health, and ...
A major development in HIV/AIDS care followed in 1995 when the FDA approved the first protease inhibitor, which is among the first highly active antiviral ... of the first PrEP medication ...
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to the chosen companies until the selected generic manufacturers are able to ...
Barchart on MSN20h
3 Top Healthcare Stocks to Buy for Growth and DividendsReal-time index price for TSX Canadian Dividend Aristocrats Index (TXDV), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
The Purpose I study, sponsored by the drug manufacturer Gilead Sciences, included 5,000 women aged 16 and 25 years in Uganda and South Africa, and tested lenacapavir against two other PrEP drugs ...
Punchng on MSN9d
LASG plans action against drug-resistant infectionsThe Lagos State Commissioner for Health, Prof Akin Abayomi, has said multidrug-resistant organisms are a major biosecurity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback